Hydroxyzine Medical Valley (Hydroxyzine Hydrochloride)

Hydroxyzine Medical Valley is a first‑generation antihistamine that acts on histamine‑mediated allergic and nervous system disorders.

• Allergic skin conditions: reduces itching and inflammation associated with urticaria or dermatitis.
• Pruritus: alleviates persistent itching caused by dermatologic disorders.
• Anxiety: provides short‑term relief of mild to moderate anxiety symptoms.
• Sedation: induces calming effect useful for pre‑operative or procedural sedation.
• Nausea and vomiting: helps control symptoms in certain acute settings.

• Hydroxyzine hydrochloride selectively blocks peripheral H1 histamine receptors, preventing histamine‑induced vasodilation, increased vascular permeability, and sensory nerve activation. It also exhibits anticholinergic activity and central nervous system depressant effects, contributing to its anxiolytic and sedative properties. The combined antihistaminic and anticholinergic actions reduce pruritus, allergic inflammation, and produce calming effects.

Hydroxyzine may cause a range of adverse reactions, from mild to serious.

Common Side Effects

• Drowsiness: feeling unusually sleepy or fatigued.
• Dry mouth: reduced salivation leading to a sticky sensation.
• Blurred vision: temporary difficulty focusing.
• Constipation: slowed gastrointestinal motility.
• Headache: mild to moderate head pain.
• Dizziness: sensation of light‑headedness or imbalance.

Serious or Rare Side Effects

• Anaphylaxis: severe allergic reaction with rash, swelling, and breathing difficulty.
• Cardiac arrhythmia: irregular heart rhythm, especially in patients with pre‑existing conditions.
• Seizures: rare occurrence of convulsive episodes.
• Hepatic dysfunction: abnormal liver enzyme elevations.
• Blood dyscrasias: rare blood cell abnormalities such as agranulocytosis.
• Prolonged QT interval: potential for dangerous heart rhythm disturbances.

Before prescribing Hydroxyzine Medical Valley, clinicians should consider several safety measures.

• Assess patient history: review allergies, cardiac disease, and hepatic function.
• Monitor CNS depression: watch for excessive sedation, especially when combined with other depressants.
• Use caution with alcohol: concurrent intake can intensify drowsiness.
• Avoid in patients with known prolonged QT: risk of cardiac arrhythmias.
• Adjust dose in hepatic impairment: reduced clearance may increase exposure.
• Store at ambient temperature: keep in the original pack, protect from moisture and direct sunlight.

Hydroxyzine can interact with other medicines, requiring careful management.

Major Interactions (Avoid)

• CNS depressants (e.g., alcohol, benzodiazepines): may cause profound sedation.
• MAO inhibitors: risk of hypertensive crisis and exaggerated anticholinergic effects.
• QT‑prolonging drugs (e.g., certain antiarrhythmics): increase risk of cardiac arrhythmias.

Moderate Interactions (Monitor Closely)

• Antihypertensives: additive blood‑pressure lowering effect.
• Other antihistamines: may enhance anticholinergic side effects.
• Opioids: combined sedation and respiratory depression potential.